RESEARCH OVERVIEW
Breast cancer represents the most commonly diagnosed cancer affecting Canadian women and is the second leading cause of cancer deaths in these patients. It is estimated that 1 in 9 women will develop breast cancer in their lifetime and 1 in 29 will die from this disease. The most devastating aspect of this disease is the development of metastatic breast cancer, which is capable of spreading from the primary tumor to distant sites in the body. Once breast cancer has spread, the disease is largely incurable. Research pursued in my laboratory focuses on defining the molecules that facilitate breast cancer metastasis and understanding the mechanisms through which they function. Thus, our research program is dedicated towards the identification of clinically relevant, functional mediators of breast cancer metastasis. It is anticipated that these candidates will represent attractive targets for the development of therapeutic agents for the management of this disease.
AFFILIATIONS & SUPPORT
Contact info
Rosalind and Morris Goodman Cancer Research Centre - McGill University
1160 Pine Ave. West (Room 508)
Montreal, Quebec (Canada)
H3A 1A3
T. 514.398.4259 (Siegel - Office)
T. 514.398.8889 (Siegel - Laboratory)
F. 514.398.6769 (Siegel - Fax)
peter.siegel@mcgill.ca
© 2011 Siegel Lab